Welcome to our dedicated page for SelectQuote news (Ticker: SLQT), a resource for investors and traders seeking the latest updates and insights on SelectQuote stock.
SelectQuote, Inc. operates a direct-to-consumer insurance distribution and healthcare services platform that connects consumers with Medicare, life, and auto and home insurance policies from carrier partners. Its model combines licensed agents, consultative needs analysis, proprietary lead sourcing and routing technology, and commission revenue from policy sales.
Recurring company developments include fiscal earnings, segment results for Senior, Healthcare Services, Life, and Auto & Home, Medicare Advantage policy volume, SelectRx membership and pharmacy economics, prescription drug reimbursement changes, and cash flow and capital-structure updates. SelectQuote also reports initiatives such as the SelectQuote Local franchise channel, research on e-broker access to Medicare Advantage, conference participation, and NYSE listing-standard compliance.
SelectQuote (NYSE: SLQT) reported fourth quarter fiscal 2026 revenue of $321.7 million, down from $345.1 million a year earlier, with a net loss of $16.8 million versus prior net income of $12.9 million. Adjusted EBITDA* rose to $11.9 million from $2.7 million, and operating cash used was $3.3 million compared to $37.5 million.
For fiscal 2026, revenue reached $1.6 billion versus $1.5 billion in 2025, with net income of $62.2 million versus $47.6 million. Adjusted EBITDA* was $109.1 million (down from $126.3 million), while operating cash flow improved to $31.9 million from negative $11.7 million. Fiscal 2027 guidance calls for revenue of $1.35–$1.45 billion, Adjusted EBITDA* of $90–$115 million, and operating cash flow of more than $60 million. Segment highlights include Senior revenue of $575.9 million with a 26% Adjusted EBITDA margin, Healthcare Services revenue of $844.9 million, and Life revenue of $186.0 million.
SelectQuote (NYSE: SLQT) will release its fiscal fourth quarter and full year 2026 financial results before market open on Tuesday, August 25, 2026. CEO Tim Danker and CFO Ryan Clement will host a conference call at 8:30 a.m. ET, accessible via webcast and pre-registered dial-in.
SelectQuote (NYSE: SLQT) announced that CFO Ryan Clement and Head of Investor Relations Matt Gunter will join a fireside chat at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2026, at approximately 11:00 a.m. ET.
Management will also hold 1x1 and small-group investor meetings.
SelectQuote (NYSE: SLQT) reported Q3 FY2026 consolidated revenue of $430.9M, net income of $40.2M, and Adjusted EBITDA of $44.6M. Fiscal 2026 guidance: revenue of $1.61B–$1.71B and Adjusted EBITDA of $90M–$100M. Key segment metrics: Senior revenue $182.9M, Healthcare Services revenue $199.4M, Life revenue $47.9M.
Operational highlights: revenue/CAC multiple 6.7X, SelectRx members 116,616 (+11% YoY), and receivables near $1B.
SelectQuote (NYSE: SLQT) will release its fiscal third quarter 2026 results before market open on May 5, 2026. CEO Tim Danker and CFO Ryan Clement will host a conference call the same day at 8:30 am ET to discuss results and answer questions.
Investors may access a live webcast via the company's investor relations site and must register for dial-in details to join the call.
SelectQuote (NYSE: SLQT) received a NYSE notice for non-compliance with Section 802.01C after its average closing price fell below $1.00 over a consecutive 30 trading-day period. The company plans to cure the deficiency within the six-month cure period and will monitor its stock price closely.
SelectQuote reported strong fiscal Q2 2026 results, completed a $415 million credit facility extending most debt maturities to 2031, and projects fiscal 2026 operating cash flow of $25M–$35M.
SelectQuote (NYSE: SLQT) announced SelectQuote Local, a franchise channel to sell senior health and life insurance through local representatives while leveraging the company’s marketing, technology, carrier relationships, and customer service.
The company said the model requires low capital from the company, aims to generate recurring royalty revenue, and complements its SelectRx pharmacy and healthcare services and a recently finalized $415 million credit facility.
SelectQuote (NYSE: SLQT) said CEO Tim Danker and CFO Ryan Clement will participate in the Mizuho 2026 Virtual Healthcare Technology Conference on March 5, 2026. Management will be available for one-on-one and small group investor meetings.
SelectQuote (NYSE: SLQT) reported Q2 FY2026 consolidated revenue of $537.1 million, net income of $69.3 million and consolidated Adjusted EBITDA of $84.7 million. Fiscal 2026 guidance: revenue of $1.61B–$1.71B and Adjusted EBITDA of $90M–$100M. Segment highlights: Senior revenue $261.5M (Adj. EBITDA $102.5M), Healthcare Services revenue $230.7M (Adj. EBITDA $0.8M), and Life revenue $43.6M. SelectRx membership reached 113,483, up 17% year-over-year.
SelectQuote (NYSE: SLQT) will release its fiscal second quarter 2026 results before market open on Thursday, February 5, 2026. CEO Tim Danker and CFO Ryan Clement will host a conference call and live webcast on February 5, 2026 at 8:00 AM ET to discuss the results.
Investors can access the live webcast on the company investor relations website and must register to receive dial-in details and unique entry codes; registration is open through the live call but early registration is recommended.